Profile picture

Professor Sergiy Koval

L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv (Ukraine)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Features of changes in the blood levels of pro-inflammatory interleukin-17A in patients with arterial hypertension, which occurs with a background  of abdominal obesity
Presentation
Features of changes in the blood levels of pro-inflammatory interleukin-17A in patients with arterial hypertension, which occurs with a background of abdominal obesity
Circulating microRNA-133a and its associations with left ventricular hypertrophy in men with arterial hypertension
Presentation
Circulating microRNA-133a and its associations with left ventricular hypertrophy in men with arterial hypertension
The onset of paroxysmal non-valvular atrial fibrillation in men with hypertension is associated with an increase in blood levels of transforming growth factor beta 1
Presentation
The onset of paroxysmal non-valvular atrial fibrillation in men with hypertension is associated with an increase in blood levels of transforming growth factor beta 1
An increase in blood levels of vascular endothelial growth factor and highly sensitive C-reactive protein in patients with hypertension and obesity is associated with the left ventricular hypertrophy
Presentation
An increase in blood levels of vascular endothelial growth factor and highly sensitive C-reactive protein in patients with hypertension and obesity is associated with the left ventricular hypertrophy
Fixed dose combination of olmesartan and amlodipine in patients with hypertension and abdominal obesity. Data of 3-month observation of efficacy and adherence to therapy
Presentation
Fixed dose combination of olmesartan and amlodipine in patients with hypertension and abdominal obesity. Data of 3-month observation of efficacy and adherence to therapy
24-hour blood pressure monitoring in hypertensive patients with abdominal obesity in the dynamics of antihypertensive treatment
Presentation
24-hour blood pressure monitoring in hypertensive patients with abdominal obesity in the dynamics of antihypertensive treatment
The associations of circulating microRNA-133a with parameters of hypertension heart disease in patients with arterial hypertension and obesity
Presentation
The associations of circulating microRNA-133a with parameters of hypertension heart disease in patients with arterial hypertension and obesity

ESC 365 is supported by